Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
Shimabukuro M, Tanaka A, Sata M, Dai K, Shibata Y, Inoue Y, Ikenaga H, Kishimoto S, Ogasawara K, Takashima A, Niki T, Arasaki O, Oshiro K, Mori Y, Ishihara M, Node K; Collaborators on the Effect of Miglitol on Glucose Metabolism in Acute Coronary Syndrome (MACS) Study. Shimabukuro M, et al. Among authors: oshiro k. Cardiovasc Diabetol. 2017 Jul 6;16(1):86. doi: 10.1186/s12933-017-0571-1. Cardiovasc Diabetol. 2017. PMID: 28683829 Free PMC article. Clinical Trial.
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.
Naito R, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Naito R, et al. JAMA Cardiol. 2022 Aug 1;7(8):787-794. doi: 10.1001/jamacardio.2022.1561. JAMA Cardiol. 2022. PMID: 35704345 Free PMC article. Clinical Trial.
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Yasuda S, et al. N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2. N Engl J Med. 2019. PMID: 31475793 Clinical Trial.
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease.
Goto S, Ogawa H, Takeuchi M, Flather MD, Bhatt DL; J-LANCELOT (Japanese-Lesson from Antagonizing the Cellular Effect of Thrombin) Investigators. Goto S, et al. Eur Heart J. 2010 Nov;31(21):2601-13. doi: 10.1093/eurheartj/ehq320. Epub 2010 Aug 30. Eur Heart J. 2010. PMID: 20805115 Free PMC article. Clinical Trial.
[An elderly case of idiopathic retroperitoneal fibrosis].
Nakada Y, Simajiri M, Shimabukuro M, Oshiro K, Nagamine F, Murakami K, Mimura G, Koyama Y, Osawa A. Nakada Y, et al. Among authors: oshiro k. Nihon Ronen Igakkai Zasshi. 1991 Nov;28(6):811-6. doi: 10.3143/geriatrics.28.811. Nihon Ronen Igakkai Zasshi. 1991. PMID: 1795444 Free article. Japanese.
[A case of recurrent syncope due to pulmonary embolism].
Nakada Y, Machida Y, Niisato T, Shimabukuro M, Ishimine M, Oshiro K, Nagamine F, Murakami K, Mimura G. Nakada Y, et al. Among authors: oshiro k. Nihon Naika Gakkai Zasshi. 1992 Aug 10;81(8):1266-7. Nihon Naika Gakkai Zasshi. 1992. PMID: 1431468 Japanese. No abstract available.
137 results